---

• n  an eye disease caused by a swelling of the macula resulting from leakage and accumulation of fluid

News & Articles

---

• iCo Therapeutics Announces Completion of Trial Enrollment and Clinical Update for iDEAL Phase 2 Study for the ...
  iCo Therapeutics Announces Completion of Trial Enrollment and Clinical Update for iDEAL Phase 2 Study for the Treatment of Diabetic Macular Edema
  June 18, 2013 - CNW Group via Yahoo! Finance
• pSivida Corp. Announces UK’s NICE Says Yes to ILUVIEN® in Some Patients with Diabetic Macular Edema in New Draft ...
  pSivida Corp. , a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the United Kingdom’s National Institute for Health and Care Excellence issued draft guidance recommending ILUVIEN® for the treatment of pseudophakic patients with chronic diabetic macular edema considered insufficiently responsive to available therapies.
  June 14, 2013 - Business Wire via Yahoo! Finance